First-Line Chemotherapy With Cisplatin Plus Fractionated Temozolomide in Recurrent Glioblastoma Multiforme: A Phase II Study of the Gruppo Italiano Cooperativo di Neuro-Oncologia - Concepedia

Concepedia

Publication | Open Access

First-Line Chemotherapy With Cisplatin Plus Fractionated Temozolomide in Recurrent Glioblastoma Multiforme: A Phase II Study of the Gruppo Italiano Cooperativo di Neuro-Oncologia

DOI Full Paper Access

113

Citations

20

References

2004

Year

Alba A. Brandes, Umberto Basso, Michele Reni, Francesca Vastola, Alicia Tosoni, Giovanna Cavallo, L. Scopece, Andrés J.M. Ferreri, Maria Grazia Panucci, S. Monfardini,

Journal of Clinical Oncology

Abstract

The new cisplatin plus bid TMZ regimen appears active in chemotherapy-naive patients with recurrent GBM and incurs an acceptable toxicity.

References

	Year	Citations

Page 1